Inclusion of People with Disabilities in Research to Improve Medication Adherence: A Systematic Review

References

• World Health Organization. Disability and health; 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/disability-and-health. Accessed March 3, 2021.
   Google Scholar
• Kitzman P, Cecil D, Kolpek JH. The risks of polypharmacy following spinal cord injury. J Spinal Cord Med. 2017;40(2):147–153. doi:10.1179/2045772314Y.0000000235
   PubMed Web of Science ®Google Scholar
• Chung P-W, Yoon B-W, Lee Y-B, et al. Medication adherence of statin users after acute ischemic stroke. Eur Neurol. 2018;80(1–2):106–114. doi:10.1159/000493530
   Web of Science ®Google Scholar
• Cyrus AC, Royer J, Carroll DD, Courtney-Long EA, McDermott S, Turk MA. Anti-hypertensive medication use and factors related to adherence among adults with intellectual and developmental disabilities. Am J Intellect Dev Disabil. 2019;124(3):248–262. doi:10.1352/1944-7558-124.3.248
   Google Scholar
• Frahm N, Hecker M, Zettl UK. Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors. Sci Rep. 2019;9(1):3743. doi:10.1038/s41598-019-40283-5
   Web of Science ®Google Scholar
• Gomides APM, Albuquerque CP, Santos ABV, et al. High levels of polypharmacy in rheumatoid arthritis-a challenge not covered by current management recommendations: Data from a large real-life study. J Pharm Pract. 2019;1:897190019869158. doi:10.1177/0897190019869158
   Web of Science ®Google Scholar
• Morgan C, McBeth J, Cordingley L, et al. The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: A study in the biologics era. Rheumatology. 2015;54(10):1780–1791. doi:10.1093/rheumatology/kev105
   PubMed Web of Science ®Google Scholar
• Remington G, Rodriguez Y, Logan D, Williamson C, Treadaway K. Facilitating medication adherence in patients with multiple sclerosis. Int J MS Care. 2013;15(1):36–45. doi:10.7224/1537-2073.2011-038
   PubMedGoogle Scholar
• Ostwald SK, Wasserman J, Davis S. Medications, comorbidities, and medical complications in stroke survivors: The CAReS Study. Rehabil Nurs. 2006;31(1):10–14. doi:10.1002/j.2048-7940.2006.tb00004.x
   PubMed Web of Science ®Google Scholar
• Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;2(11):CD000011. doi:10.1002/14651858.CD000011.pub4
   Web of Science ®Google Scholar
• Cherubini A, Oristrell J, Pla X, et al. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med. 2011;171(6):550–556. doi:10.1001/archinternmed.2011.31
   PubMedGoogle Scholar
• Clark LT, Watkins L, Piña IL, et al. Increasing diversity in clinical trials: Overcoming Critical Barriers. Curr Probl Cardiol. 2019;44(5):148–172. doi:10.1016/j.cpcardiol.2018.11.002
   PubMed Web of Science ®Google Scholar
• Duma N, Vera Aguilera J, Paludo J, et al. Representation of minorities and women in oncology clinical trials: Review of the past 14 years. J Oncol Pract. 2017;14(1):e1–e10. doi:10.1200/JOP.2017.025288
   Web of Science ®Google Scholar
• Tahhan AS, Vaduganathan M, Greene SJ, et al. Enrollment of older patients, women, and racial and ethnic minorities in contemporary heart failure clinical trials: A systematic review. JAMA Cardiol. 2018;3(10):1011–1019. doi:10.1001/jamacardio.2018.2559
   PubMed Web of Science ®Google Scholar
• Freedman VA, Spillman BC. Active life expectancy in the older US population, 1982–2011: Differences between Blacks and Whites persisted. Health Aff Proj Hope. 2016;35(8):1351–1358. doi:10.1377/hlthaff.2015.1247
   Web of Science ®Google Scholar
• Spong CY, Bianchi DW. Improving Ppublic health requires inclusion of underrepresented populations in research. JAMA. 2018;319(4):337–338. doi:10.1001/jama.2017.19138
   PubMed Web of Science ®Google Scholar
• Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME. Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. J Natl Cancer Inst. 2019;111(3):245–255. doi:10.1093/jnci/djy221
   PubMedGoogle Scholar
• Al Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol. 2009;67(5):547–557. doi:10.1111/j.1365-2125.2009.03391.x
   PubMed Web of Science ®Google Scholar
• Tilson JK. Validation of the modified Fresno Test: Assessing physical therapists’ evidence based practice knowledge and skills. BMC Med Educ. 2010;10(1):38. doi:10.1186/1472-6920-10-38
   Web of Science ®Google Scholar
• Mullan RJ, Montori VM, Shah ND, et al. The diabetes mellitus medication choice decision aid: A randomized trial. Arch Intern Med. 2009;169(17):1560–1568. doi:10.1001/archinternmed.2009.293
   PubMedGoogle Scholar
• Matsumura K, Arima H, Tominaga M, et al. Does a combination pill of antihypertensive drugs improve medication adherence in Japanese? A randomized controlled trial. Circ J Off J Jpn Circ Soc. 2012;76(6):1415–1422. doi:10.1253/circj.cj-11-1481
   Web of Science ®Google Scholar
• Márquez Contreras E, Casado Martínez JJ, Motero Carrasco J, et al. Therapy compliance in cases of hyperlipaemia, as measured through electronic monitors. Is a reminder calendar to avoid forgetfulness effective? Aten Primaria. 2007;39(12):661–668. doi:10.1157/13113960
   Web of Science ®Google Scholar
• Johnson MO, Dilworth SE, Taylor JM, Neilands TB. Improving coping dkills for self-management of treatment side rffects can reduce antiretroviral medication nonadherence among people living with HIV. Ann Behav Med. 2011;41(1):83–91. doi:10.1007/s12160-010-9230-4
   PubMed Web of Science ®Google Scholar
• Bennett H, Laird K, Margolius D, Ngo V, Thom DH, Bodenheimer T. The effectiveness of health coaching, home blood pressure monitoring, and home-titration in controlling hypertension among low-income patients: protocol for a randomized controlled trial. BMC Public Health. 2009;9:456. doi:10.1186/1471-2458-9-456
   Web of Science ®Google Scholar
• Márquez-Contreras E, Martell-Claros N, Gil-Guillén V, et al. Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: The EAPACUM–HTA study. J Hypertens. 2006;24(1):169–175. doi:10.1097/01.hjh.0000198023.53859.a2
   PubMed Web of Science ®Google Scholar
• Duggan AP, Bradshaw YS, Swergold N, Altman W. When rapport building extends beyond affiliation: Communication overaccommodation toward patients with disabilities. Perm J. 2011;15(2):23–30. doi:10.7812/TPP/11-018
   Google Scholar
• Sabatello M. Cultivating inclusivity in precision medicine research: Disability, diversity, and cultural competence. J Community Genet. 2019;10(3):363–373. doi:10.1007/s12687-018-0402-4
   PubMed Web of Science ®Google Scholar